Director/Sr. Director, R&D Strategy Jobs in Cambridge, MA at Moderna Therapeutics

Title: Director/Sr. Director, R&D Strategy

Company: Moderna Therapeutics

Location: Cambridge, MA

Salary: $200K – $250K*

Category: Pharmaceuticals & Biotech

Job Description

The Role:

Reporting to the Head, R&D Strategy, the Director/Senior Director, R&D Strategy will play a key role in integrating and communicating our strategy from discovery through development and across therapeutic areas (TAs). Working closely with senior leadership across Research and Development, this position will orchestrate TA strategic reviews and help integrate perspectives from discovery through development, will generate and maintain an integrated view of our R&D pipeline and critical catalysts to inform portfolio strategy and long-range planning, and will support communication of key topics with executives and cross-functional leadership.

Here’s What You’ll Do:

In collaboration with TA CSO, TA Development Head, and R&D Strategy colleagues, drive integration of discovery and preclinical/early clinical development program strategies and contribute TA-level strategic input, culminating in holistic TA strategy

With TA CSO, TA Development Head, and CDO, run annual TA strategy and program review process to prioritize efforts, ensure alignment on direction and objectives, and support consistency in evaluation across TAs

Create unified view of key catalysts within TAs and across portfolio to inform decision-making and cross-functional strategies (e.g., Corporate, CMC)

Develop forward-looking pipeline and productivity perspective and support aligned resource planning during annual Long-Range Planning process

Support on-going portfolio strategy and opportunity and risk analysis and prepare communications for executive and leadership teams to maintain visibility and shared understanding of portfolio performance and to solicit feedback

Drive key strategic evaluations outside of planned TA and LRP assessments

Here’s What You’ll Bring to the Table:

5-10 years of experience working for a pharmaceutical/biotech company in strategy or corporate development, or similar experience in a professional services or investment capacity (e.g., management or strategy consulting, investment banking, private equity, or venture capital)

PhD, MD, or PharmD preferred, and familiarity with industry research and clinical development

Sharp analytical capabilities in assessment of programs, therapeutic areas, portfolios, and companies

Breadth and depth as a thought partner for colleagues across functions and levels, including ability to synthesize diverse inputs

Advanced verbal and written communication skills to drive organizational clarity in decision-making, rationale, implications, and actions

Professional gravitas necessary to make impactful first impressions

Embody the Moderna values: BOLD in imagining what’s possible; RELENTLESS in overcoming obstacles and driving to conclusions; COLLABORATIVE in working with, learning from, and teaching others; and CURIOUS in learning about cutting edge science

Here’s What We’ll Bring to the Table:

On-site subsidized cafeteria or catered lunches

Company-provided iPhone

Free parking, monthly subway pass or a subsidized commuter rail pass

Free annual corporate membership to Bluebikes

Highly competitive healthcare coverage including: medical offered through BCBS (HMO/PPO), dental, and vision offered through VSP

Flexible Spending Accounts for medical expenses and dependent care expenses

16 weeks of 100% paid parental leave for all new parents

16 weeks 100% paid family caregiver leave

20 weeks 100% paid medical leave

Eligible for “Moderna Month” …


About Moderna Therapeutics

Moderna Therapeutics is a biotechnology company that researches and develops protein therapies based on novel messenger RNA (mRNA) technology. The company’s technology uses mRNA made of nucleotide analogs to trigger the body’s natural processes to produce proteins inside the human cell. This approach has the potential to produce therapeutic proteins in vivo to treat a wide range of diseases, including those that cannot be effectively treated with existing methods to develop and manufacture drugs. Moderna’s pipeline of mRNA product candidates covers a broad expanse of drug modalities, including vaccines (both for infectious diseases and personalized cancer vaccines), intracellular/transmembrane proteins, intratumoral expression, and secreted antibodies and proteins. Each modality represents a distinct approach to using the mRNA platform to encode proteins that achieve a therapeutic benefit, enabling the company to develop numerous drug candidates across a wide array of therapeutic areas. The company was founded in 2011 in Cambridge, Massachusetts through funding from Flagship Ventures. Moderna’s founders include Noubar Afeyan of Flagship Ventures, Kenneth R. Chien of Harvard University and the Karolinska Institutet, Robert S. Langer of the Massachusetts Institute of Technology and Derrick Rossi of Boston Children’s Hospital. Moderna is led by Stéphane Bancel, CEO and Director of the Board; Stephen Hoge, M.D., President; Marcello Damiani, Chief Digital Officer; Annie Seibold Drapeau, Chief Human Resources Officer, Steven W. Harbin, SVP, Manufacturing and Operations; Saqib Islam, Chief Business Officer; Jim R. Kasinger, J.D., General Counsel; Lorence Kim, M.D., CFO, and Tal Zaks, M.D., Ph.D., CMO.